SCHEMBL6744558

SCHEMBL6744558

CC(=O)c1cc(OC(C)C)ccc1Br

nearest known ligand 0.58

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
POLB P06746 2/20 0.47
KMT2A Q03164 1/20 0.47
PARP10 Q53GL7 1/20 0.46
HPGD P15428 2/20 0.46
GLA P06280 1/20 0.42
BRD4 O60885 1/20 0.41
BRPF1 P55201 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A3 P47895 1/20 0.40
TSPO P30536 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
ACACB O00763 2/20 0.39
ACACA Q13085 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4649906 0.87 ALDH1A1 (0.71) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL1652968 0.83 ALDH1A1 (0.59) ALDH1A1POLBKMT2AHPGDMAOB
SCHEMBL13263811 0.79 ALDH1A1 (0.59) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL7646688 0.79 ALDH1A1 (0.59) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL3988817 0.79 KDM4E (0.57) ALDH1A1KMT2APARP10MAOAMAOB
SCHEMBL9256790 0.78 ALDH1A1 (0.47) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL13265124 0.78 ALDH1A1 (0.58) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL31617906 0.77 ALDH1A1 (0.47) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL16481265 0.76 ALDH1A1 (0.46) ALDH1A1POLBKMT2APARP10HPGD
SCHEMBL7657654 0.76 MAOB (0.47) KMT2AMAOAMAOBMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374794-B1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2015-11-04 EP disclosed
EP-2374788-B1 INDANYL COMPOUNDS DAIICHI SANKYO CO LTD (JP) 2013-04-03 EP disclosed
US-8183272-B2 Indanyl compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-22 US disclosed
US-8183272-B2 Indanyl compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-22 US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-8173631-B2 Cyclic amine compounds DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-05-08 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319468-A1 CYCLIC AMINE COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319359-A1 INDANYL COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
US-20110319359-A1 INDANYL COMPOUNDS DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-12-29 US disclosed
EP-2374794-A1 CYCLIC AMINE COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 EP disclosed
EP-2374788-A1 INDANYL COMPOUNDS Daiichi Sankyo Company, Limited (JP) 2011-10-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319468-A1 CYCLIC AMINE COMPOUNDS RYR2, CASR, RYR1 ALDH1A1 2584/4885POLB 3807/4885KMT2A 2928/4885
US-20110319359-A1 INDANYL COMPOUNDS RYR2, ORAI1, CASR ALDH1A1 2138/4885POLB 4830/4885KMT2A 4655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.